Drug recall · September 19, 2018
Diltiazem HCl Extended-Release Capsules recall
Why: Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Diltiazem HCl Extended-Release Capsules, USP 120 mg 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-05
- Lots / codes
Batch code # 3093163, expiration date 04/2019
- Quantity
- 656 500-count bottles
- Company
- Mylan Pharmaceuticals Inc., Morgantown, WV
- Distribution
- Distributed Nationwide in the US
- Initiated
- August 7, 2018 · Voluntary: Firm initiated
- Classified
- September 10, 2018
- Reported
- September 19, 2018
- Ended
- August 14, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diltiazem
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.